Therapy Areas: Vaccines
9 November 2018 - - US-based biopharmaceutical company Sensei Biotherapeutics, Inc will highlight clinical and immunological data from the Phase 1 clinical trial of SNS-301 in a poster presentation at...
9 November 2018 - - French clinical stage biotech company Enyo Pharma has completed its phase Ib clinical trial evaluating the safety, pharmacokinetics and pharmacodynamics of its FXR agonist compound...
9 November 2018 - Immunicum AB (STO:IMMU), a biopharmaceutical company developing therapeutic cancer vaccines, on Thursday reported that at the Extraordinary General Meeting, held on 8 November 2018, ...
8 November 2018 - - Austrian immunomodulation therapies developer Themis Bioscience has published the Phase 2 results of its lead vaccine candidate (MV-CHIK) in The Lancet, the company said....
8 November 2018 - Myovant Sciences Ltd (NYSE: MYOV), a clinical-stage biopharmaceutical company focused on developing and commercialising innovative therapies for women's health and endocrine dis...
8 November 2018 - Immunicum AB (STO:IMMUB), a biopharmaceutical company developing therapeutic cancer vaccines, on Wednesday reported net loss of SEK23.52m, or SEK0.5 per diluted share, in the third q...
Related Headlines